These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28951672)

  • 1. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
    Sales I; Aljadhey H; Albogami Y; Mahmoud MA
    Saudi Pharm J; 2017 Sep; 25(6):868-872. PubMed ID: 28951672
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
    Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.
    Alghazwani Y; Alqahtani AM; Alshuraymi MK; Assiri IM; Shuflut AA; Krishnaraju V; Kumarappan C; Ibrahim ARN; Orayj K
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1667-1680. PubMed ID: 36876701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge, attitude, and practice regarding pharmacovigilance among the general public in Western China: a cross-sectional study.
    Chen Y; Wang Y; Wang N; Xiang Y; Zhang R; Xiao J; Liu H; Feng B
    Curr Med Res Opin; 2021 Jan; 37(1):101-108. PubMed ID: 33136523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Suyagh M; Farah D; Abu Farha R
    Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.
    Alkayyal N; Cheema E; Hadi MA
    Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental reporting of adverse drug reactions in South Africa: An online survey.
    Pillay S; Mulubwa M; Viljoen M
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
    Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
    Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.